Panome Bio Inc.
New Form D on file · 2024-11-21 · the record
Before you sell to, join or invest in Panome Bio Inc.
MentionFox check on Panome Bio Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/panome-bio-inc-form-d-24000001
Check Panome Bio Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Panome Bio Inc. filed a Form D with the Securities and Exchange Commission on 2024-11-21.
Panome Bio Inc. filed a Form D notice of an exempt securities offering with the SEC on November 21, 2024. The filing reports $6M sold. Its industry group is Biotechnology. It names Edward Weinstein (Executive Officer, Director), Tom Cohen (Executive Officer), Rob Capone (Director) (SEC Form D, November 21, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Panome Bio Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-11-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Panome Bio Inc.
Free to see. No signup.
Get an email when Panome Bio Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Panome Bio Inc. raises, hires or launches. No email unless you switch it on.
Watch Panome Bio Inc. →Get the full cited report on Panome Bio Inc.
What the filing shows about Panome Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Panome Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Panome Bio Inc.'s address as 4340 Duncan Avenue, Saint Louis, MO 63110.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Panome Bio Inc. is a registered filer with the SEC (CIK 1966691) and has filed since 2023-02-24. 2 filings are on record, the latest on 2024-11-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Panome Bio Inc.'s Form D of 2024-11-21 names Edward Weinstein, Tom Cohen, Rob Capone and 2 more as its officers, directors or promoters.
Its new offerings report $11.97M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
A portion of the proceeds will be used for general working capital, which may include salary payments to executive officers and directors. An estimate of such amount is unknown at this time.
Edward Weinstein is named as Executive Officer and Director on the Form D that Panome Bio Inc. filed with the SEC on 21 November 2024, one of 5 people that filing names.
Tom Cohen is named as Executive Officer on the Form D that Panome Bio Inc. filed with the SEC on 21 November 2024, one of 5 people that filing names.
Rob Capone is named as Director on the Form D that Panome Bio Inc. filed with the SEC on 21 November 2024, one of 5 people that filing names.
Deval Lashkari is named as Director on the Form D that Panome Bio Inc. filed with the SEC on 21 November 2024, one of 5 people that filing names.
David Smoller is named as Director on the Form D that Panome Bio Inc. filed with the SEC on 21 November 2024, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2024-11-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Panome Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Panome Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Panome Bio Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Panome Bio Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Panome Bio Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Panome Bio Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in St. Louis
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/panome-bio-inc-form-d-24000001